share_log

StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

StockNews.com 开始报道中国制药（纽约证券交易所代码：CPHI）
kopsource ·  2023/01/27 04:53

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Get Rating) in a research report released on Tuesday morning. The brokerage issued a hold rating on the stock.

StockNews.com 开始报道的股票 中国制药（纽约证券交易所代码：CPHI-获取评级） 在周二上午发布的研究报告中。该经纪公司对该股发布了持有评级。

China Pharma Price Performance

中国医药价格表现

Shares of CPHI opened at $0.10 on Tuesday. The firm has a market capitalization of $5.42 million, a PE ratio of -1.31 and a beta of 0.69. China Pharma has a 1-year low of $0.08 and a 1-year high of $0.53. The company's fifty day moving average price is $0.11 and its 200-day moving average price is $0.15.

CPHI的股价周二开盘价为0.10美元。该公司的市值为542万美元，市盈率为-1.31，beta值为0.69。中国制药的1年低点为0.08美元，1年高点为0.53美元。该公司的五十天移动平均线价格为0.11美元，其200天移动平均线价格为0.15美元。

Get
获取
China Pharma
中国制药
alerts:
警报：

China Pharma Company Profile

中国制药公司简介

(Get Rating)

（获取评分）

China Pharma Holdings, Inc engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products.
China Pharma Holdings, Inc从事药品的开发、制造和营销。该公司的产品组合包括中枢神经系统（CNS）和脑心血管疾病、抗感染和呼吸系统疾病、消化系统疾病、综合医疗保健和保护产品。

See Also

另见

  • Get a free copy of the StockNews.com research report on China Pharma (CPHI)
  • Does Oil Services Firm NOV Have Enough Energy To Maintain Rally?
  • Shopify Clears Cup-With-Handle Base: Can Momentum Continue?
  • The Future Of E-Commerce: Analysis And New Data
  • Chevron Delights Shareholders with $75 Billion in Share Buybacks
  • Levi Strauss Is A Good Fit For Income Investors
  • 免费获取 StockNews.com 关于中国制药 (CPHI) 的研究报告
  • 石油服务公司NOV有足够的能量来维持涨势吗？
  • Shopify 清理了带手柄的杯子底座：势头能否持续下去？
  • 电子商务的未来：分析和新数据
  • 雪佛龙通过750亿美元的股票回购使股东感到高兴
  • 李维·施特劳斯非常适合收入投资者

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.

接收《中国医药日报》的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收中国制药及相关公司的最新新闻和分析师评级的简要每日摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发